Cargando…

The Use of a New Dedicated Electrocautery Lumen-Apposing Metal Stent for Gallbladder Drainage in Patients with Acute Cholecystitis

Aims: Lumen-apposing metal stents (LAMSs) in ultrasonography-guided gallbladder drainage (EUS-GBD) have become increasingly important for high-risk surgical patients. Our study aims to evaluate the technical and clinical success, safety, and feasibility of endoscopic ultrasonography-guided gallbladd...

Descripción completa

Detalles Bibliográficos
Autores principales: Brandaleone, Luca, Franchellucci, Gianluca, Facciorusso, Antonio, Samanta, Jayanta, Moon, Jong Ho, Vargas-Madrigal, Jorge, Robles Medranda, Carlos, Barbera, Carmelo, Di Matteo, Francesco, Bulajic, Milutin, Auriemma, Francesco, Paduano, Danilo, Calabrese, Federica, Gentile, Carmine, Massidda, Marco, Bianchi, Marco, De Luca, Luca, Polverini, Davide, Masoni, Benedetta, Poletti, Valeria, Marcozzi, Giacomo, Hassan, Cesare, Repici, Alessandro, Mangiavillano, Benedetto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10650170/
https://www.ncbi.nlm.nih.gov/pubmed/37958236
http://dx.doi.org/10.3390/diagnostics13213341
Descripción
Sumario:Aims: Lumen-apposing metal stents (LAMSs) in ultrasonography-guided gallbladder drainage (EUS-GBD) have become increasingly important for high-risk surgical patients. Our study aims to evaluate the technical and clinical success, safety, and feasibility of endoscopic ultrasonography-guided gallbladder drainage using a new dedicated LAMS. Methods: This is a retrospective multicenter study that included all consecutive patients not suitable for surgery who were referred to a tertiary center for EUS-GBD using a new dedicated electrocautery LAMS for acute cholecystitis at eight different centers. Results: Our study included 54 patients with a mean age of 76.48 years (standard deviation: 12.6 years). Out of the 54 endoscopic gallbladder drainages performed, 24 (44.4%) were cholecysto-gastrostomy, and 30 (55.4%) were cholecysto-duodenostomy. The technical success of LAMS placement was 100%, and clinical success was achieved in 23 out of 30 patients (76.67%). Adverse events were observed in two patients (5.6%). Patients were discharged after a median of 5 days post-stenting. Conclusions: EUS-GBD represents a valuable option for high-surgical-risk patients with acute cholecystitis. This new dedicated LAMS has demonstrated a high rate of technical and clinical success, along with a high level of safety.